VANTAGEPOINT INVESTMENT ADVISERS LLCVANTAGEPOINT INVESTMENT ADVISERS LLC

Institutional investor · Portfolio as of Q2 2025

Top Holdings7 positions

Checking export access…
Activity:
IVVIVV
ETF

ISHARES TR

524,120$325.4M32.6%$554.98+10.24%
21 qtrssince 2020-Q2
Increased
100
AGGAGG
ETF

ISHARES TR

3M$295.4M29.6%$91.62+3.38%
21 qtrssince 2020-Q2
Decreased
0
TLTTLT
ETF

ISHARES TR

2.1M$184.8M18.5%$91.28-8.25%
13 qtrssince 2022-Q2
Decreased
0
SPHYSPHY
ETF

SPDR SER TR

7.5M$177.8M17.8%$20.90+3.48%
2 qtrssince 2025-Q1
Increased
63
VTVVTV
ETF

VANGUARD INDEX FDS

37,720$6.7M0.7%$148.23+16.25%
13 qtrssince 2022-Q2
Decreased
0
VUGVUG
ETF

VANGUARD INDEX FDS

8,500$3.7M0.4%$34.90+108.23%
12 qtrssince 2022-Q3
Unchanged
0
VCSHVCSH
ETF

VANGUARD SCOTTSDALE FDS

40,800$3.2M0.3%$72.57+6.52%
5 qtrssince 2024-Q2
Decreased
0
$997.1M
AUM
7
Positions
Q2 2025
Filing
HI score · 1.0/5
Quarterly 13F Value Change
-19%Q1'24$604.4M+20%Q2'24$726.7M+7%Q3'24$779.1M-20%Q4'24$624.1M+41%Q1'25$877.1M+14%Q2'25$997.1M
Activity profile
$ moved · Q2'25
New0%Increased67%Decreased28%Exited6%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.5 years
<1Q0%1-4Q14%1-2Y0%2Y+86%

VANTAGEPOINT INVESTMENT ADVISERS LLC manages $997.1M across 7 positions as of Q2 2025. Top holdings: IVV (32.6%), AGG (29.6%), TLT (18.5%). Fund DNA: Steady Compounder. HoldingsIntel Score: 1/5.0.

Q2 2025 Summary

Exited 2, increased 2, trimmed 4. Top move: IVV (INCREASED, conviction 100). Portfolio: $997M across 7 positions.

Top holdings by portfolio weight

Total AUM$997M
IVV32.64%
AGG29.63%
TLT18.54%
SPHY17.83%
VTV0.67%
VUG0.37%
VCSH0.33%
IGSB0.00%
VANGUARD BD 0.00%

Portfolio allocation by GICS sector

Sectors1
Unknown100.00%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Unknown
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Weak(1.0 / 5.0)
Holdings P&L84
Conviction49
Concentration51
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
4Q
VUGVUGVanguard Index Funds MORNINGSTAR GROWTH ETF
Q3 2025 → Q2 2026+6.8M shares+$581.2M
3Q
AVEMAVEMAVANTIS EMERGING MARKETS EQUITY ETF
Q4 2025 → Q2 2026+126,777 shares+$60.7M
2Q
VWOVWOVanguard International Equity Index Funds FTSE EMR MKT ETF
Q1 2026 → Q2 2026+521,392 shares+$44.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used